Group B Streptococcal Cellulitis-Adenitis Syndrome in Infants: Insights From 24 Years of Experience

Ana Del Valle Penella; Christopher C Pretorius; Carol J Baker; Marcia A Rench; Catherine Mary Healy; Morven S Edwards

doi:10.1093/jpids/piac033

Group B Streptococcal Cellulitis-Adenitis Syndrome in Infants: Insights From 24 Years of Experience

J Pediatric Infect Dis Soc. 2022 Aug 30;11(8):375-378. doi: 10.1093/jpids/piac033.

Authors

Ana Del Valle Penella¹, Christopher C Pretorius², Carol J Baker³, Marcia A Rench¹, Catherine Mary Healy¹, Morven S Edwards¹

Affiliations

¹ Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
² Department of Pediatrics, Kaiser Permanente Medicine, Mid-Atlantic Permanente Medical Group, Washington, DC, USA.
³ Department of Pediatrics, University of Texas Health Science Center, McGovern Medical School, Houston, Texas, USA.

PMID: 35552426
DOI: 10.1093/jpids/piac033

Abstract

This series of 28 infants with group B streptococcal (GBS) cellulitis-adenitis from a single institution over 24 years offers insights important to the early recognition, spectrum of findings, and optimal management of this rare manifestation of invasive GBS disease.

Keywords: bacteremia; cellulitis-adenitis; group B Streptococcus; neonatal sepsis.

© The Author(s) 2022. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: [email protected].

Publication types

Case Reports

MeSH terms

Cellulitis / drug therapy
Humans
Infant
Lymphadenitis*
Streptococcal Infections* / complications
Streptococcal Infections* / diagnosis
Streptococcal Infections* / drug therapy
Streptococcus agalactiae
Syndrome